Global (United States, European Union and China) Vasomotor Symptoms of Menopause Treatment Market Research Report 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
• 1.4 Market by Type
  • 1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Estetrol
  • 1.4.3 Fezolinetant
  • 1.4.4 FP-101
  • 1.4.5 HBN-2
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Homecare
  • 1.5.4 Clinic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2015-2026)
• 2.2 Global Vasomotor Symptoms of Menopause Treatment Growth Trends by Regions
  • 2.2.1 Vasomotor Symptoms of Menopause Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Vasomotor Symptoms of Menopause Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Vasomotor Symptoms of Menopause Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Market Size
  • 3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
  • 3.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2019
• 3.3 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
• 3.4 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
• 3.5 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)
• 5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 6.2 Vasomotor Symptoms of Menopause Treatment Key Players in North America (2019-2020)
• 6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 6.4 North America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 7.2 Vasomotor Symptoms of Menopause Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 7.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 8.2 Vasomotor Symptoms of Menopause Treatment Key Players in China (2019-2020)
• 8.3 China Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 8.4 China Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 9.2 Vasomotor Symptoms of Menopause Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 9.4 Japan Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 10.2 Vasomotor Symptoms of Menopause Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 11.2 Vasomotor Symptoms of Menopause Treatment Key Players in India (2019-2020)
• 11.3 India Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 11.4 India Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size (2015-2020)
• 12.2 Vasomotor Symptoms of Menopause Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Vasomotor Symptoms of Menopause Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Amgen Inc.
  • 13.1.1 Amgen Inc. Company Details
  • 13.1.2 Amgen Inc. Business Overview
  • 13.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020))
  • 13.1.5 Amgen Inc. Recent Development
• 13.2 EndoCeutics, Inc.
  • 13.2.1 EndoCeutics, Inc. Company Details
  • 13.2.2 EndoCeutics, Inc. Business Overview
  • 13.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.2.5 EndoCeutics, Inc. Recent Development
• 13.3 Euroscreen S.A.
  • 13.3.1 Euroscreen S.A. Company Details
  • 13.3.2 Euroscreen S.A. Business Overview
  • 13.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.3.5 Euroscreen S.A. Recent Development
• 13.4 MenoGeniX, Inc.
  • 13.4.1 MenoGeniX, Inc. Company Details
  • 13.4.2 MenoGeniX, Inc. Business Overview
  • 13.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.4.5 MenoGeniX, Inc. Recent Development
• 13.5 Mithra Pharmaceuticals S.A.
  • 13.5.1 Mithra Pharmaceuticals S.A. Company Details
  • 13.5.2 Mithra Pharmaceuticals S.A. Business Overview
  • 13.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.5.5 Mithra Pharmaceuticals S.A. Recent Development
• 13.6 Pherin Pharmaceuticals, Inc.
  • 13.6.1 Pherin Pharmaceuticals, Inc. Company Details
  • 13.6.2 Pherin Pharmaceuticals, Inc. Business Overview
  • 13.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.6.5 Pherin Pharmaceuticals, Inc. Recent Development
• 13.7 Pivot Pharmaceuticals Inc
  • 13.7.1 Pivot Pharmaceuticals Inc Company Details
  • 13.7.2 Pivot Pharmaceuticals Inc Business Overview
  • 13.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.7.5 Pivot Pharmaceuticals Inc Recent Development
• 13.8 Radius Health, Inc.
  • 13.8.1 Radius Health, Inc. Company Details
  • 13.8.2 Radius Health, Inc. Business Overview
  • 13.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.8.5 Radius Health, Inc. Recent Development
• 13.9 TherapeuticsMD, Inc.
  • 13.9.1 TherapeuticsMD, Inc. Company Details
  • 13.9.2 TherapeuticsMD, Inc. Business Overview
  • 13.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
  • 13.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2015-2020)
  • 13.9.5 TherapeuticsMD, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer